Expert Review of Hematology

Article	Citations
Are we closer to a standard of care for Richter’s syndrome? Novel treatments on the horizon	54
Hemophagocytic lymphohistiocytosis in Egyptian children: diagnosis, treatment challenges, and outcome	53
Immune thrombocytopenia and pregnancy: challenges and opportunities in diagnosis and management	43
Do we need more guidance on thrombophilia testing? Challenges and special considerations	36
Hematological parameters and X-ray exposure among medical radiation workers: a systematic review and meta-analysis	34
A combination of carfilzomib, dexamethasone, and daratumumab for treatment of adult patients with relapsed/refractory multiple myeloma in two dosing regimens: once-weekly and twice-weekly	26
Frequencies of glycosylphosphatidylinositol (GPI)-deficient cells using high-sensitivity flow cytometry as per the 2018 ICCS/ESCCA consensus guideline in patients with hematologic malignancy, aplastic	25
Acalabrutinib: a bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemia	25
What is the future of digital tools to help manage pain in sickle cell disease patients?	23
From bench to bedside: bridging the gaps in best practices for real-world chronic myeloid leukemia care	23
Phase II single-arm study of brentuximab vedotin in Chinese patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large cell lymphoma	23
Treating sickle cell disease in resource-limited sub-Saharan Africa: recent strategies and recommendations in addressing the gaps for the provision of evidence-based management	22
Upfront therapy for diffuse large B-cell lymphoma: looking beyond R-CHOP	21
Treatment patterns and blood count control in 10,112 patients with polycythemia vera	21
The evolving management algorithm for the patient with newly diagnosed cold agglutinin disease	21
COVID-19 associated with immune thrombocytopenia: a systematic review and meta-analysis	21
Are myelodysplastic syndromes ready for venetoclax? Exploring future potential and considerations	20
Correlation between hematocrit and the risk of common human cancers: results of a 1999–2020 observational survey and Mendelian randomization analysis	19
Allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: current status and future directions mainly focusing on a Chinese perspective	18
Late effects of hemopoietic stem cell transplant for sickle cell disease: monitoring and management	17
BTK inhibitors: moving the needle on the treatment of chronic lymphocytic leukemia	15
Screening and interventional strategies for the late effects and toxicities of hematological malignancy treatments in pediatric survivors	15
The future of siRNA-mediated approaches to treat von Willebrand disease	15
Relapse and resistance in acute myeloid leukemia post venetoclax: improving second lines therapy and combinations	15
Extended post-discharge thromboprophylaxis in hospitalized COVID-19 patients	15

Past, present, and future of orthopedic surgery in hemophilia: looking to a world without bleeding and arthropathy in the near future	14
Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera	14
Impact of atrial fibrillation in onco-hematological patients in Europe: a targeted literature review	12
Cost-effectiveness analysis of azacitidine maintenance therapy in patients with acute myeloid leukemia	12
Etranacogene dezaparvovec for the treatment of adult patients with severe and moderately severe hemophilia B	12
Efficacy and safety of phosphatidylinositol 3-kinase inhibitors in patients with chronic lymphocytic leukemia: a meta-analysis and systematic review	12
Efanesoctocog alfa for the prevention and treatment of bleeding in patients with hemophilia A	12
Bone marrow aspirate or biopsy for multiple myeloma: when percentages matter!	12
Sickle cell disease and infertility risks: implications for counseling and care of affected girls and women	12
BCL-2 inhibition in acute myeloid leukemia: resistance and combinations	11
New directions to develop therapies for people with hemophilia	11
Patient-centered care in von Willebrand disease: are we there yet?	11
Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients	11
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and funding	10
Radiation therapy prior to CAR T-cell therapy in lymphoma: impact on patient outcomes	10
Voxelotor for the treatment of sickle cell disease in pediatric patients	10
The National Hemophilia Foundation’s State of the Science Research Summit: the foundation of a national research blueprint for inherited bleeding disorders	10
Is next-generation sequencing the future of measurable residual disease assays for Philadelphia chromosome-positive acute lymphoblastic leukemia?	10
Thrombotic events in children and adolescent patients with SARS-CoV-2 infection: a systematic review with meta-analysis on incidence and management	10
Optimizing long-term joint health in the treatment of hemophilia	10
Development and internal validation of a prediction model for patients with hematologic diseases of fall risk: a cohort study	10
Managing blood supplies during natural disasters, humanitarian emergencies, and pandemics: lessons learned from COVID-19	10
Molecular targets for the treatment of AML in the forthcoming 5th World Health Organization Classification of Haematolymphoid Tumours	9
Emicizumab and unmet needs of patients with hemophilia a who are managed with replacement therapies	9
Dose optimisation of ponatinib in chronic phase chronic myeloid leukemia	9
Rivaroxaban plus aspirin after lower–extremity revascularization	9
A real-world evidence analysis of the impact of switching from factor VIII to emicizumab prophylaxis in patients with hemophilia A without inhibitors	9
Real-world treatment patterns and outcomes in people with von Willebrand disease treated prophylactically with recombinant von Willebrand factor in the United States	9
What is the importance of monitoring iron levels in different organs over time with magnetic resonance imaging in transfusion-dependent thalassemia patients?	9
A review of the isocitrate dehydrogenase inhibitors in management of adult patients with AML and MDS	8
Pegcetacoplan: the first and only C3-targeted therapy for the treatment of adults with paroxysmal nocturnal hemoglobinuria	8
Role of volumetric analyses on [18F]FDG PET/CT in pediatric Hodgkin lymphoma	8
Hematology in the post-COVID era: spotlight on vaccine-induced immune thrombotic thrombocytopenia and a conceptual framework (the 4P’s) for anti-PF4 diseases	8
Oral decitabine in acute myeloid leukemia: assessing efficacy, safety, and future implications for older patients	8
The impact of oral health promotion on the quality of life of children with bleeding disorders: fighting misconceptions	8
Is the occurrence of deep vein thrombosis related to the fracture site? A two-sample Mendelian randomization study	8
Bad players in AL amyloidosis in the current era of treatment	8
Long-term follow-up of patients with hairy cell leukemia in the south of Iran	8
Lived experience experts: a name created by us for us	8
Curative effect of motherwort combined with ethinylestradiol-cyproterone acetate on dysfunctional uterine bleeding	7
Bridging the gap: how do we enroll more racial-ethnic minority patients in hematological drug trials?	7
Revisiting the prognostic role of FLT3 mutations in acute myelogenous leukemia	7
Monoclonal antibodies used for the management of hemataological disorders	7
Problems faced by people with hemophilia aged 18–35 years in social life: a qualitative study	7
Exploring health disparities in diagnosing multiple myeloma	7
Hematological disorders in children with Down syndrome	7
Pomalidomide combined with dexamethasone for the treatment of relapsed/refractory multiple myeloma: a systematic review and meta-analysis	7
An update on novel therapies for treating patients with arterial thrombosis	7
Advances in our understanding of genetic markers and targeted therapies for pediatric LCH	7
Sickle cell disease in gulf cooperation council countries: a systematic review	7

Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders	7
Bone marrow morphological features and therapy in patients with Philadelphia-negative neoplasms	7
Genetic variant of endothelial protein C receptor genes and its serum level in B thalassemic children	7
Trends of chronic lymphocytic leukemia incidence and mortality in the United States: a population-based study over the last four decades	7
Advancements in targeting CD30 for lymphoma therapy: a historical perspective and future directions	7
Novel mechanisms of action of emerging therapies of hereditary thrombotic thrombocytopenic purpura	7
Mesenchymal stromal cells for the prophylaxis of graft-versus-host disease after hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials	7
Exploring the genetic relationship between deep vein thrombosis and plasma protein: a new research idea	6
Targeting von Willebrand disease: the current status and future directions of management therapies	6
Challenges facing minimal residual disease testing for acute myeloid leukemia and promising strategies to overcome them	6
Identifying prognostic gene panels in acute myeloid leukemia	6
Development of CD30 CAR-T cells in refractory or relapsed Hodgkin’s lymphoma	6
An observational study of disease management in adult patients with polycythemia vera: results from a large U.S. claims database	6
Understanding the interplay between chronic lymphocytic leukemia and type 2 diabetes	6
Revisiting the role of measurable residual disease in FLT3 mutated acute myelogenous leukemia	6
Secondary primary malignancies after treatment with chemo-immunotherapy in treatment-naïve patients with CLL: a systematic literature review	6
Challenges in the diagnosis of thrombotic thrombocytopenic purpura	6
Improving outcomes and quality of life for patients with transfusion-dependent β-thalassemia: recommendations for best clinical practice and the use of novel treatment strategies	6
Navigating the gap between guidelines and practical challenges in selecting first-line therapy for chronic lymphocytic leukemia	6
An evaluation of mitapivat for the treatment of hemolytic anemia in adults with pyruvate kinase deficiency	6
HIV-1 infection in sickle cell disease and sickle cell trait: role of iron and innate response	6
New approaches to managing relapsed/refractory Hodgkin lymphoma: the role of checkpoint inhibitors and beyond	6
Practical tips for managing FLT3 mutated acute myeloid leukemia with midostaurin	6
Novel BCR-ABL1 tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia	6
Circ_0035381 contributes to the progression of acute myeloid leukemia via regulating miR-186-5p/CDCA3 pathway	6
Kompetitive allele specific PCR (KASP) based genotyping of sickle gene in the selected sub-ethnic tribal population of Gujarat and Madhya Pradesh	6
A systematic literature review of the epidemiology, quality of life, and economic burden, including disease pathways and treatment patterns of relapsed/refractory classical Hodgkin lymphoma	6
Pacritinib for the treatment of patients with myelofibrosis and thrombocytopenia	5
Targeting CD123 in BPDCN: an emerging field	5
Immunotherapy for myelodysplastic syndrome and acute myeloid leukemia: where do we stand?	5
Vasculopathy among children and adolescents with sickle cell disease: the crosstalk with annexin A1, vitamin D, and myocardial iron overload	5
Characterizing the ideal patient for treatment with inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: a systematic literature review	5
Efficacy and safety evaluation of eptacog beta (coagulation factor VIIa [recombinant]-jncw) for the treatment of hemophilia A and B with inhibitors	5
How clinicians and persons with hemophilia may approach shared decision-making	5
Revolutionizing hypertension treatment: aprocitentan’s dual action against resistant hypertension	5
A new decade awaits sticky platelet syndrome: where are we now, how do we manage and what are the complications?	5
Effectiveness of myofascial therapy (MFT) along with traditional physiotherapy and intermittent prophylaxis on short-term improvement of joint health in hemophilic arthropathy: a randomized control tr	5
Modifiable lifestyle risk factors and survival after diagnosis with multiple myeloma	5
NSAIDS/COXIBS for the treatment of musculoskeletal pain secondary to hemophilic arthropathy	5
Incidence, prevention and management of severe infections in patients undergoing therapy for chronic lymphocytic leukemia	5
Five decades of successive establishment of hemophilia care in Thailand	5
Anti-tissue factor pathway inhibitors for hemophilia: are these treatments the answer to overcoming current treatment limitations?	5
The role of staging in multiple myeloma	5
Avapritinib for Systemic Mastocytosis	5
The benefits of early intervention using lenalidomide for high-risk smoldering multiple myeloma: emerging data and its promising clinical impact	4
Challenges and considerations for antifungal prophylaxis in children with acute myeloid leukemia	4
Addressing unmet needs in rare bleeding disorders: selected poster extracts of recent research in hemophilia A and von Willebrand disease presented at the 14th Annual Congress of the European Associat	4
Cognitive impairment in hematology patients planned for chimeric antigen receptor T-cell therapy	4
Magnitude of anemia and associated factors among adult patients at Baso Liben District: a cross-sectional study	4
Evaluating ravulizumab for the treatment of children and adolescents with paroxysmal nocturnal hemoglobinuria	4
Managing patients with myelofibrosis and thrombocytopenia	4
An evaluation of fedratinib for adult patients with newly diagnosed and previously treated myelofibrosis	4
Novel approaches for preventing COVID-19 infection in immunocompromised patients with hematologic malignancies	4
Relationship between the ABO blood group and Rhesus factors with COVID-19 susceptibility	4
The prognostic power of MMP-9 in diffuse large B-cell lymphoma	4
Proactive measures to reduce maternal mortality and post-partum hemorrhage in sub-Saharan Africa: the hematology perspective	4
CircPTK2 promotes cell viability, cell cycle process, and glycolysis and inhibits cell apoptosis in acute myeloid leukemia by regulating miR-582-3p/ALG3 axis	4
Real-world treatment patterns and outcomes of triple-class treated patients with multiple myeloma in the United States	4
Advances in viral oncolytics for treatment of multiple myeloma – a focused review	4
Exploring the rationale for red cell transfusion in myelodysplastic syndrome patients: emerging data and future insights	4
Current evidence on the use of direct oral anticoagulants in patients with myeloproliferative neoplasm: a systematic review	4
Copper deficiency, a rare but correctable cause of pancytopenia: a review of literature	4
An overview of novel therapies in advanced clinical testing for acute myeloid leukemia	4
Comparison of blinatumomab and CAR T-cell therapy in relapsed/refractory acute lymphoblastic leukemia: a systematic review and meta-analysis	4
t(4;14), and revised myeloma comorbidity index as good predictors of survival for multiple myeloma	4
CD8+CD25+ Tregs as a predictor of glucocorticoid sensitivity in patients with immune thrombocytopenia	4
Effect of hydroxyurea on erythrocyte apoptosis in hemoglobinopathy patients	4
Procalcitonin as a diagnostic marker for infection in sickle cell disease	4
An evaluation of deferiprone as twice-a-day tablets or in combination therapy for the treatment of transfusional iron overload in thalassemia syndromes	4
Long non-coding RNA LOC644135 is a potential prognostic indicator in cytogenetically normal acute myeloid leukemia	4
Inhibitor eradication and treatment for acquired hemophilia A	4
A deep dive into future therapies for microcytic anemias and clinical considerations	4
Nutritional status of patients with lymphoproliferative neoplasms before and after the first-line treatment	4
Letter to the Editor on “Hematopoietic cell transplants in resource-poor countries: challenges and opportunities”	4
The past, the present and the future of immune checkpoints inhibitors in multiple myeloma	4
Evaluating zanubrutinib for the treatment of adults with chronic lymphocytic leukemia or small lymphocytic lymphoma	3
Is intensive chemotherapy and allogeneic stem cell transplantation mandatory for curing Philadelphia chromosome-positive acute lymphoblastic leukemia in young patients in the era of multitarget agents	3
Novel treatments for immune thrombocytopenia: targeting platelet autoantibodies	3
Next generation anticoagulants: a spotlight on the potential role of activated factors XII and XI	3
New developments in the diagnosis and characterization of Waldenström’s macroglobulinemia	3

Emerging roles of microRNAs in acute lymphoblastic leukemia and their clinical prospects	3
Identifying people with acute lymphoblastic leukemia who are most suitable for treatment with inotuzumab ozogamicin: a plain language summary	3
Pregnancy and sickle cell disease: an overview of complications and suggested perinatal care	3
The role of intraarticular injections of hyaluronic acid in joint pain relief in hemophilic arthropathy	3
Efficacy and safety of thrombopoietin receptor agonists in the treatment of thrombocytopenia after hematopoietic stem cell transplantation: a meta-analysis and systematic review	3
Foreword: a special focus on bleeding disorders	3
Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infection	3
The National Hemophilia Foundation State of the Science Research Summit initiative: executive summary	3
Transplant-associated thrombotic microangiopathy: elucidating prevention strategies and identifying high-risk patients	3
The potential of triplet combination therapies for patients with FLT3-ITD -mutated acute myeloid leukemia	3
Reduction of ristocetin-induced platelet aggregation (RIPA) during storage despite plasma renewal: evidence for hemostatic importance of GPIbα shedding	3
G-CSF primary prophylaxis use and outcomes in patients receiving chemotherapy at intermediate risk for febrile neutropenia: a scoping review	3
Emerging small molecular inhibitors as targeted therapies for high-risk acute myeloid leukemias	3
Dysregulated MAPK signaling pathway in acute myeloid leukemia with RUNX1 mutations	3
Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis	3
Post-transplant sorafenib effectively prevents relapse in FLT3-mutated acute myeloid leukemia	3
Thrombo-vera: a new thrombosis risk model for polycythemia vera using modern variable selection methods	3
The promise of novel treatments for severe chronic neutropenia	3
Correction	3
Proximal complement inhibitors in paroxysmal nocturnal hemoglobinuria: an abundance of options in a rare disease	3
Overexpression of SCN5A overcomes ABC transporter-mediated multidrug resistance in acute myeloid leukemia through promoting apoptosis	3
Clinical study on the prevention of deep vein thrombosis in patients with external fixation of lower limb fractures using an automatic ankle pump movement ceramic moxibustion rehabilitation device	3
Update on iron supplementation in patients with cancer-related anemia	3
Positron emission tomography/magnetic resonance imaging (PET/MRI) vs. gastroscopy: Can it improve detection of extranodal marginal zone lymphomas of the stomach following H. pylori treatment?	3
To enhance the detection of aplastic anemia in primary care settings: a population-based study in Italy	3
Soliciting international perspectives on an American national research agenda for inherited bleeding disorders	3
Effect of days of age at first blood transfusion on intraventricular hemorrhage in very low and extremely low birth weight infants	2
Anemia and iron overload as prognostic markers of outcomes in β-thalassemia	2
Quality of life considerations in myelodysplastic syndrome: not only fatigue	2
Could targeted gene insertion of factor 9 be a potential durable treatment for Hemophilia B?	2
Factor first! Emergency department management of persons with hemophilia: a single-center study	2
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia	2
Emicizumab: a novel drug in hemophilia A prophylaxis – a narrative review	2
Looking to the future of gene therapy for hemophilia A and B	2
Immune thrombocytopenia: a review on the pathogenetic role of immune cells	2
Addressing thrombosis concerns in immune thrombocytopenia: the role of fostamatinib in immune thrombocytopenia management	2
How will genomic testing impact a clinician’s choice for managing chronic myeloid leukemia?	2
Enoxaparin adherence for venous thromboembolism prophylaxis in hospitalized patients with sickle cell disease	2
Preformed anti-HLA DQA1/DQB1 DSA possibly responsible for graft failure in haploidentical stem cell transplantation	2
Identification and management of fetal anemia due to hemolytic disease	2
Cyclophosphamide and horse anti-thymocyte globulin versus fludarabine, reduced cyclophosphamide and rabbit anti-thymocyte globulin conditioning regimen for allogeneic hematopoietic stem cell transplan	2
Polycythemia vera: aspects of its current diagnosis and initial treatment	2
Current therapies for chronic lymphocytic leukemia: risk and prophylaxis strategies for secondary/opportunistic infections	2
Keeping a balance in chronic lymphocytic leukemia (CLL) patients taking ibrutinib: ibrutinib-associated adverse events and their management based on drug interactions	2
A systematic review of histological characteristics in arterial and venous thrombi	2
Quality of life considerations and management in patients with myelodysplastic syndrome	2
Gastrointestinal bleeding in von Willebrand patients: special diagnostic and management considerations	2
An evaluation of von Willebrand factor (recombinant) therapy for adult patients living with severe type 3 von Willebrand disease	2
MiR-106b-5p, MiR-200c-3p, and MiR-146a-5p expression as putative biomarkers for disease state in primary immune thrombocytopenia	2
DNA damage repair in megakaryopoiesis: molecular and clinical aspects	2
Is 50 mg/day the new standard dose of dasatinib in newly diagnosed patients with chronic myeloid leukemia in chronic phase?	2
Safety of FLT3 inhibitors in patients with acute myeloid leukemia	2
Best practices and recommendations for drug regimens and plasma exchange for immune thrombotic thrombocytopenic purpura	2
Improving care for systemic light-chain amyloidosis patients: is a multidisciplinary approach best?	2
Reduced CXCR4 expression in associated with extramedullary and predicts poor survival in newly diagnosed multiple myeloma	2
Synchronizing the use of allogeneic hematopoietic cell transplantation in checkpoint blockade therapy for Hodgkin lymphoma	2
The efficiency of autologous stem cell transplantation as the first-line treatment for nodal peripheral T-cell lymphoma: results of a systematic review and meta-analysis	2
Modulation of the endocannabinoid system in chronic conditions: a potential therapeutic intervention yet to be explored in sickle cell disease	2
The diagnosis, natural history, and management of von Willebrand disease in women in the age of guidelines	2
Platelet indices in preeclampsia: comparative analysis with normotensive pregnant women	2
Subanesthetic ketamine: the way forward for pain management in sickle cell disease patients?	2
Olutasidenib: a novel mutant IDH1 inhibitor for the treatment of relapsed or refractory acute myeloid leukemia	2
Ankle arthrodesis and total ankle replacement in patients with congenital bleeding disorders suffering from severe ankle arthropathy	2
Redefining efficacy and safety endpoints for chronic lymphocytic leukemia in the era of targeted therapy	2
Global prophylaxis trends in hemophilia: a macroeconomic analysis and its association with world development indicators	2
Assessing eligibility for treatment in acute myeloid leukemia in 2023	1
Real-world study of rurioctocog alfa pegol and emicizumab in US clinical practice among patients with hemophilia A	1
Investigation of demographic features, performance, comorbidity status and mortality causes among multiple myeloma patients: real-life data	1
Management of acute chest syndrome in patients with sickle cell disease: a systematic review of randomized clinical trials	1
Emerging data on thrombopoietin receptor agonists for management of chemotherapy-induced thrombocytopenia	1
Advances in myelodysplastic syndromes: promising novel agents and combination strategies	1
A systematic review of the predicted outcomes related to hematopoietic stem cell transplantation: focus on applied machine learning methods’ performance	1
Immunogenicity, safety, and efficacy of rurioctocog alfa pegol in previously untreated patients with severe hemophilia A: interim results from a phase 3, prospective, multicenter, open-label study	1
In the era of primary prophylaxis in hemophilia, what types of orthopedic surgical interventions have been published in the 2020–2023 period and in which countries?	1
Clinical trials, challenges, and changes in TCR-based therapeutics for hematologic malignancies	1
Evaluation of the effect of voxelotor and darbepoetin alfa on hemoglobin levels in patients with sickle cell disease	1
An interview with Dr. Jean A. Yared on his experience as an investigator for obecabtagene autoleucel - by Reegan Burnell-Clarke (Commissioning Editor)	1
Efficacy of azacitidine in preventing relapse after hematopoietic stem cell transplantation for advanced myeloid malignancies: a systematic review and meta-analysis	1
What are the therapeutic options for previously treated myelofibrosis?	1
Complement-directed therapy for cold agglutinin disease: sutimlimab	1
An expert review of voxelotor for the treatment of hemolytic anemia in patients with sickle cell disease: ‘bridging the gap between laboratory data and patient related outcomes’	1
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disorders	1
Clinical status of induction therapy incorporating a hypomethylating agent for newly diagnosed adult acute myeloid leukemia compared to the standard 7+3 regimen	1
Total elbow arthroplasty in hemophilia: a high-risk surgical procedure	1
Trends in non-Hodgkin lymphoma mortality: global, regional, and national insights from 1990 to 2021	1
Frontline combination of dasatinib and low-intensity chemotherapy in adults with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia	1
A narrative review of consolidation strategies for young and fit patients with newly-diagnosed primary central nervous system lymphoma	1
Exercise and anemia in cancer patients: could it make the difference?	1
Efficacy and safety of caplacizumab in the treatment of thrombotic thrombocytopenic purpura: a systematic review and meta-analysis	1
Nodular lymphocyte-predominant Hodgkin lymphoma: current management strategies and evolving approaches to individualize treatment	1
Current state-of-the-art of immunotherapy in follicular lymphoma	1
Clinical characteristics of HFE C282Y/H63D compound heterozygotes identified in a specialty practice: key differences from HFE C282Y homoz	1
Risk of vaso-occlusive episodes in patients with sickle cell disease exposed to systemic corticosteroids: a comprehensive review	1
Graft-versus-host disease after an outpatient peripheral blood hematopoietic cell transplant using reduced-intensity conditioning: a single-center LATAM experience	1
Utilizing the prognostic impact of minimal residual disease in treatment decisions for pediatric acute lymphoblastic leukemia	1